Photoswitch drug shows early signs of restoring light sensitivity in severely damaged retinas in first human trial
AI Summary
Researchers at Adelaide University have conducted the first human trial of a photoswitch drug aimed at restoring light sensitivity in severely damaged retinas. Early results show promise for treatment of a leading cause of blindness in working-age adults.
Adelaide University researchers have carried out the first in-human trial of a new type of treatment for a leading cause of blindness in working age adults, with promising results.